Public and patient involvement (PPI) has been identified as an increasingly desired and,
often, required component of trial methodology–leading to higher quality, more accessible …

Background Randomised controlled trials (RCTs) are considered particularly likely to benefit
from patient and public involvement (PPI). Decisions made by professional researchers at …

Patient and public involvement (PPI) in research is increasingly required, although evidence
to inform its implementation is limited. Objective Inform the evidence base by describing how …

Background Patient and public involvement (PPI), inclusion of members of the public as
active partners in the research process, can be a requirement of research funding. Limited …

Background While patient and public involvement (PPI) in clinical trials is beneficial and
mandated by some funders, formal guidance on how to implement PPI is limited and …

Background Patient and public involvement (PPI) is advocated in clinical trials yet evidence
on how to optimise its impact is limited. We explored researchers' and PPI contributors' …

Background Patient and public involvement (PPI) in research has increased steadily over
the last two decades and is now both expected and appropriately resourced by many …

Background Patient and public involvement (PPI) in clinical trial design contributes to
ensuring the research objectives and outcome measures are relevant to patients. The …

Plain Language Summary Funders of research are increasingly requiring researchers to
involve patients and the public in their research. Patient and public involvement (PPI) in …

Background Patient and public involvement (PPI) in clinical trials aims to ensure that
research is carried out collaboratively with patients and/or members of the public. However …